Shanshan Sui

Title: Inventor Shanshan Sui: Pioneering Pharmaceutical Innovations in Cancer Treatment

Introduction

Shanshan Sui, an accomplished inventor based in Lianyungang, China, is making significant strides in the pharmaceutical industry. With one patent to her name, she is at the forefront of developing innovative treatments, specifically targeting cancer therapies. Her work demonstrates a commitment to advancing medical science and improving patient outcomes.

Latest Patents

Sui's notable patent is for a pharmaceutical composition of a MEK inhibitor. This patent describes a composition that incorporates 6-(2-chloro-4-iodophenylamino)-N-(2-hydroxyethoxy)-5-methyl-4-oxo-4,5-dihydrofuro[3,2-c]pyridine-7-carboxamide or a pharmaceutically acceptable salt, along with a binder, a surface stabilizer, and a dispersant. The innovative aspect of this pharmaceutical composition is its ability to create a suspension that can be dispersed in water, achieving a median particle size ranging from 0.5 µm to 4.0 µm. This advancement is particularly important in the formulation of medications for treating various cancers.

Career Highlights

Shanshan Sui is currently associated with Chia Tai Tianqing Pharmaceutical Group Co., Ltd., a leading company in the pharmaceutical sector. Her role involves continuous research and development to create effective pharmaceutical solutions. This position has enabled her to leverage her expertise and contribute to groundbreaking innovations in cancer treatment.

Collaborations

Throughout her career, Sui has collaborated with notable coworkers, including Xiongxiong He and Ping Dong. These partnerships reflect her commitment to teamwork in the scientific community and highlight the importance of collaboration in the innovation process. Together, they work towards enhancing the efficacy and safety of pharmaceutical products.

Conclusion

Inventor Shanshan Sui exemplifies the spirit of innovation in the field of pharmaceuticals, especially in the context of cancer treatment. With her groundbreaking patent and collaborative approach, she is poised to make a lasting impact on the industry. As advancements in medicine continue to unfold, Sui's contributions will undoubtedly play a crucial role in improving healthcare outcomes for patients worldwide.